Review
Open access
Sep 2026
Cross‐Neutralization Responses and Persistent Symptoms After SARS‐CoV‐2 Breakthrough Infections
The cross‐NAb landscape in a real‐world Chinese population after a 3‐year zero‐COVID strategy is defined, showing modest broadening of humoral immunity following multiple exposures, but antigenic divergence of emerging Omicron sub‐variants continues to limit cross‐protection, supporting the need for variant‐adapted vac...
Ting Yang, Rong Zhang, Shi-Jie Qin et al.
· Journal of Medical Virology · 0 citations